Health Canada inspection
Amicogen (China) Biopharm Co Ltd.: Health Canada inspection of Aug 30, 2024
Health Canada · GMP · rating C
Key facts
| Establishment | Amicogen (China) Biopharm Co Ltd. |
|---|---|
| City | Jining |
| Province | Shandong |
| Country | China |
| Program | GMP |
| Start date | Aug 23, 2024 |
| End date | Aug 30, 2024 |
| Rating | C |
| Rating description | Compliant |
| Licence number | Not applicable |
At a glance
- 1–9 Inspections of this establishment
- No Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.